SCHEMBL9944847

SCHEMBL9944847

CCNC(=O)c1cc(N)c(NC)cc1N1CCC(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 4/20 0.43
HSD17B10 Q99714 2/20 0.43
POLB P06746 2/20 0.43
NR4A1 P22736 1/20 0.43
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
TSHR P16473 1/20 0.40
ALOX15 P16050 1/20 0.39
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
BRPF1 P55201 1/20 0.37
ATM Q13315 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944806 0.91 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944821 0.91 ALOX15 (0.39) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944750 0.87 PTGES (0.37) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL9944760 0.83 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944846 0.82 KMT2A (0.47) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL9944799 0.82 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944991 0.82 KDM4E (0.36) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL9944829 0.79 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944824 0.79 CA2 (0.40) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL9944826 0.79 RAB9A (0.41) ALDH1A1KDM4EHPGDMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885KDM4E 3442/4885HPGD 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.